Literature DB >> 1391679

Distribution of carbamazepine and its epoxide in blood compartments in adolescent and adult epileptic patients.

J Bonneton1, P Genton, E Mesdjian.   

Abstract

Carbamazepine (CBZ) used in the treatment of epilepsy, is metabolized in man to an active metabolite: carbamazepine 10-11 epoxide (CBZ-E). CBZ and CBZ-E concentrations in the different blood compartments (plasma ultrafiltrate, plasma proteins, and red blood cells (RBC)) of epileptic patients on CBZ monotherapy were assessed using HPLC. The highest CBZ and CBZ-E level to dose ratios were observed in the RBC. For CBZ and CBZ-E significant correlations were found between some blood compartments particularly between RBC and plasma ultrafiltrate. The measurement of CBZ and CBZ-E in all blood compartments may be interesting in uncontrolled patients and in patients presenting side-effects which cannot be explained by total plasma concentration values.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1391679     DOI: 10.1002/bdd.2510130604

Source DB:  PubMed          Journal:  Biopharm Drug Dispos        ISSN: 0142-2782            Impact factor:   1.627


  3 in total

1.  Pharmacokinetic simulation of fatal carbamazepine intoxication in 23-month old child following phenytoin discontinuation.

Authors:  Jineane V Venci; Meghan M Rowcliffe; Lance Wollenberg; Michelle M Rainka; Fran M Gengo
Journal:  Forensic Sci Med Pathol       Date:  2012-08-23       Impact factor: 2.007

2.  Clinical validation and implications of dried blood spot sampling of carbamazepine, valproic acid and phenytoin in patients with epilepsy.

Authors:  Sing Teang Kong; Shih-Hui Lim; Wee Beng Lee; Pasikanthi Kishore Kumar; Hwee Yi Stella Wang; Yan Lam Shannon Ng; Pei Shieen Wong; Paul C Ho
Journal:  PLoS One       Date:  2014-09-25       Impact factor: 3.240

Review 3.  Therapeutic Drug Monitoring of Antiseizure Medications Using Volumetric Absorptive Microsampling: Where Are We?

Authors:  Annachiara D'Urso; Marcello Locatelli; Angela Tartaglia; Linda Molteni; Cristian D'Ovidio; Fabio Savini; James Rudge; Ugo de Grazia
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.